Soko Setoguchi, MD, DrPH, a cardiologist by training, board-certified internist, and epidemiologist, is Associate Professor of Medicine and Epidemiology, Director of Clinical Research Education, Department of Medicine, Rutgers Robert Wood Johnson Medical School (RWJMS) and at Rutgers School of Public Health. She is also the new Co-Director of the Master of Science in Clinical and Translational Science (MS-CTS) at Rutgers School of Graduate Studies. After her medical school and training in Cardiology in Japan, she completed her doctoral training in epidemiology at the Harvard School of Public Health. She was on the research faculty in the Division of Pharmacoepidemiology at Brigham and Women’s Hospital and at Duke Clinical Research Institute. She then completed US residency training in Internal Medicine at University of North Carolina Hospital and RWJMS in 2017. Dr. Setoguchi is recognized as an international leader in the field of pharmacoepidemiology, the study of the health effects of medications and other medical products in populations. She has authored more than 120 peer-reviewed papers in leading medical journals and has been funded by both federal and non-federal sources for her pharmacoepidemiology research program. Her research uses large databases to perform health services and outcomes research and comparative effectiveness research for medications and implantable medical devices in patients with chronic disease. Her work is internationally regarded for its methodological rigor and creativity. Her research not only produced critical evidence to improve health outcomes of patients, but also advanced the methods in pharmacoepidemiology using large databases through new approaches linking multiple databases, linking mothers and babies within databases, and developing creative study designs and applications of sophisticated methods. As she tackled important research questions, she used, promoted, and developed/tested new design-based methods and statistical methods as needed to conduct valid studies providing these answers. Dr. Setoguchi has led multiple initiatives and activities within the International Society of Pharmacoepidemiology, serving as chair/member of the organizing committee for the annual international and Asian conferences and director of educational sessions for Asian conferences. She has been a member of several national committees and boards, including FDA’s Drug Safety and Risk Management Advisory Committee, review panels for NIH and AHRQ, and the editorial board for Pharmacoepidemiology and Drug Safety. She recently completed US residency training, pursuing her passion for patient care and conducting clinically relevant research as a clinician-scientist. In her new role as a clinician-scientist, she has been developing and directing new initiatives for clinical research education for medical trainees and has lead an NIH training grant application to support residents to conduct mentored research during residency. As the new Co-Director of the MSCTS program at Rutgers School of Graduate Studies, she has been remaking the program to inspire and train the next generation of clinician-scientists.